The question of T2a and N3a in the UICC/AJCC (1997) staging system for nasopharyngeal carcinoma [3]

Clinical Oncology

Volumn 16, Issue 8, 2004, Pages 581-583

  Low, J S H ^a   Heng, D M K ^b   Wee, J T S ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b Clinical Trials and Epidemiology Research Unit   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; LETTER; MALE; NASOPHARYNX CARCINOMA; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; SAMPLE SIZE; SINGAPORE; STANDARDIZATION;

ADULT; CARCINOMA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 8744240291     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.08.003     Document Type: Letter

References (3)

1. A.W.M. Lee J.S.K. Au P.M.L. Teo et al. Staging of nasopharyngeal carcinoma: Suggestions for improving the current UICC/AJCC staging system Clin Oncol 16 2004 269-276
2. D.M.K. Heng J. Wee K.W. Fong et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal cancer Cancer 86 1999 1912-1920
3. J.C. Lin W.Y. Wang K.Y. Chen et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 2004 2452-2460